These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 12697943)

  • 1. Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control.
    Schnell FM
    Oncologist; 2003; 8(2):187-98. PubMed ID: 12697943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis.
    Natale JJ
    Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recent improvements in antiemetic therapy].
    Roila F; Palladino MA; Ciccarese G; Basurto C
    Tumori; 1997; 83(2 Suppl):S3-14. PubMed ID: 9235727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan.
    Tamura K; Aiba K; Saeki T; Nakanishi Y; Kamura T; Baba H; Yoshida K; Yamamoto N; Kitagawa Y; Maehara Y; Shimokawa M; Hirata K; Kitajima M;
    Int J Clin Oncol; 2015 Oct; 20(5):855-65. PubMed ID: 25681876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence and treatment of chemotherapy-induced nausea and emesis in gastrointestinal cancer].
    Lorenzen S; Spörl S; Lordick F
    Z Gastroenterol; 2014 Aug; 52(8):821-30. PubMed ID: 25111723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
    Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
    J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Options in the treatment of chemotherapy-induced emesis.
    Pendergrass KB
    Cancer Pract; 1998; 6(5):276-81. PubMed ID: 9767346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and delayed nausea and emesis control in pediatric oncology patients.
    Holdsworth MT; Raisch DW; Frost J
    Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and control of chemotherapy-induced nausea and vomiting].
    Gómez-Raposo C; Feliú-Batlle J; González-Baróna M
    Med Clin (Barc); 2006 Feb; 126(4):143-51. PubMed ID: 16472500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced nausea and vomiting: incidence and characteristics of persistent symptoms and future directions NCCTG N08C3 (Alliance).
    Kottschade L; Novotny P; Lyss A; Mazurczak M; Loprinzi C; Barton D
    Support Care Cancer; 2016 Jun; 24(6):2661-7. PubMed ID: 26768436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities.
    Del Favero A; Roila F; Tonato M
    Drug Saf; 1993 Dec; 9(6):410-28. PubMed ID: 7510495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Yarker YE; McTavish D
    Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ondansetron: a pharmacoeconomic and quality-of-life evaluation of its antiemetic activity in patients receiving cancer chemotherapy.
    Plosker GL; Milne RJ
    Pharmacoeconomics; 1992 Oct; 2(4):285-304. PubMed ID: 10147044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New developments in the treatment of nausea and vomiting caused by chemotherapy].
    de Wit R; van Alphen MM
    Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principles of managing chemotherapy-induced nausea and vomiting].
    Takiuchi H; Kawabe S; Goto M; Ota S; Kii T; Tanaka T; Nishitani H; Kuwakado S; Katsu K
    Gan To Kagaku Ryoho; 2006 Jan; 33(1):19-23. PubMed ID: 16410692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nausea and vomiting].
    Fujii M
    Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.